Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1996 Sep;70(9):6036–6043. doi: 10.1128/jvi.70.9.6036-6043.1996

Mutational analysis of the envelope protein of spleen necrosis virus.

I Martinez 1, R Dornburg 1
PMCID: PMC190624  PMID: 8709226

Abstract

Spleen necrosis virus (SNV) is an amphotropic type C retrovirus originally isolated from a duck. The envelope protein is related to that of type D retroviruses, and SNV appears to use the same receptor as do simian retroviruses. However, little is known about envelope-receptor interactions of SNV. We constructed a series of envelope mutants to characterize the SU peptide of SNV. Point mutations were introduced throughout SU in regions that are conserved among all retroviruses belonging to the same receptor interference group. The biological and biochemical properties of these mutants were analyzed. All mutants were transported efficiently to the cell surface. Almost all mutations in the amino-terminal one-third caused a conformational change of the envelope and a significant drop in infectivity and abolished the ability to confer superinfection interference. Similar observations were made with only two of seven mutants with mutations in the middle of SU. Four mutations in this region had little or no effect on biological activity. One mutant envelope protein (Asp to Arg at position 192) was processed normally but showed little infectivity and had no ability to confer superinfection interference. A detailed mutational analysis suggested that this amino acid forms a hydrogen bond to its cellular receptor. Mutations within the carboxy-terminal part of SU had very little or no effect on biological function. Aberrantly processed envelope proteins were proteolytically cleaved at a new point upstream of and differing in sequence from the conserved retroviral SU/TM cleavage site. Surprisingly, these mutants still retained some infectivity (0.01 to 1% of that of the wild type). Our data indicate that the envelope of SNV behaves in a manner very different from that of the envelopes of other studied retroviruses.

Full Text

The Full Text of this article is available as a PDF (572.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbacid M., Daniel M. D., Aaronson S. A. Immunological relationships of OMC-1, an endogenous virus of owl monkeys, with mammalian and avian type C viruses. J Virol. 1980 Jan;33(1):561–566. doi: 10.1128/jvi.33.1.561-566.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Battini J. L., Danos O., Heard J. M. Receptor-binding domain of murine leukemia virus envelope glycoproteins. J Virol. 1995 Feb;69(2):713–719. doi: 10.1128/jvi.69.2.713-719.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Battini J. L., Heard J. M., Danos O. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J Virol. 1992 Mar;66(3):1468–1475. doi: 10.1128/jvi.66.3.1468-1475.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Charman H. P., Gilden R. V., Oroszlan S. Reticuloendotheliosis virus: detection of immunological relationship to mammalian type C retroviruses. J Virol. 1979 Mar;29(3):1221–1225. doi: 10.1128/jvi.29.3.1221-1225.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen P. Y., Cui Z., Lee L. F., Witter R. L. Serologic differences among nondefective reticuloendotheliosis viruses. Arch Virol. 1987;93(3-4):233–245. doi: 10.1007/BF01310977. [DOI] [PubMed] [Google Scholar]
  6. Chu T. H., Dornburg R. Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J Virol. 1995 Apr;69(4):2659–2663. doi: 10.1128/jvi.69.4.2659-2663.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chu T. H., Martinez I., Olson P., Dornburg R. Highly efficient eukaryotic gene expression vectors for peptide secretion. Biotechniques. 1995 May;18(5):890-6, 898-9. [PubMed] [Google Scholar]
  8. Chu T. H., Martinez I., Sheay W. C., Dornburg R. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins. Gene Ther. 1994 Sep;1(5):292–299. [PubMed] [Google Scholar]
  9. Cui Z. Z., Lee L. F., Silva R. F., Witter R. L. Monoclonal antibodies against avian reticuloendotheliosis virus: identification of strain-specific and strain-common epitopes. J Immunol. 1986 Jun 1;136(11):4237–4242. [PubMed] [Google Scholar]
  10. Delwart E. L., Panganiban A. T. Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference. J Virol. 1989 Jan;63(1):273–280. doi: 10.1128/jvi.63.1.273-280.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Devereux J., Haeberli P., Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 1984 Jan 11;12(1 Pt 1):387–395. doi: 10.1093/nar/12.1part1.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dornburg R. Reticuloendotheliosis viruses and derived vectors. Gene Ther. 1995 Jul;2(5):301–310. [PubMed] [Google Scholar]
  13. Dougherty J. P., Temin H. M. A promoterless retroviral vector indicates that there are sequences in U3 required for 3' RNA processing. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1197–1201. doi: 10.1073/pnas.84.5.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dowbenko D., Nakamura G., Fennie C., Shimasaki C., Riddle L., Harris R., Gregory T., Lasky L. Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies. J Virol. 1988 Dec;62(12):4703–4711. doi: 10.1128/jvi.62.12.4703-4711.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dubay J. W., Roberts S. J., Brody B., Hunter E. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J Virol. 1992 Aug;66(8):4748–4756. doi: 10.1128/jvi.66.8.4748-4756.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Einfeld D. A., Hunter E. Expression of the TM protein of Rous sarcoma virus in the absence of SU shows that this domain is capable of oligomerization and intracellular transport. J Virol. 1994 Apr;68(4):2513–2520. doi: 10.1128/jvi.68.4.2513-2520.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gilmore T. D., Temin H. M. Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T. Cell. 1986 Mar 14;44(5):791–800. doi: 10.1016/0092-8674(86)90845-7. [DOI] [PubMed] [Google Scholar]
  18. Gray K. D., Roth M. J. Mutational analysis of the envelope gene of Moloney murine leukemia virus. J Virol. 1993 Jun;67(6):3489–3496. doi: 10.1128/jvi.67.6.3489-3496.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gritz L., Davies J. Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene. 1983 Nov;25(2-3):179–188. doi: 10.1016/0378-1119(83)90223-8. [DOI] [PubMed] [Google Scholar]
  20. Gu J., Parthasarathi S., Varela-Echavarría A., Ron Y., Dougherty J. P. Mutations of conserved cysteine residues in the CWLC motif of the oncoretrovirus SU protein affect maturation and translocation. Virology. 1995 Feb 1;206(2):885–893. doi: 10.1006/viro.1995.1011. [DOI] [PubMed] [Google Scholar]
  21. Hunter E., Swanstrom R. Retrovirus envelope glycoproteins. Curr Top Microbiol Immunol. 1990;157:187–253. doi: 10.1007/978-3-642-75218-6_7. [DOI] [PubMed] [Google Scholar]
  22. Kang C. Y., Temin H. M. Lack of sequence homology among RNAs of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken endogenous RNA-directed DNA polymerase activity. J Virol. 1973 Dec;12(6):1314–1324. doi: 10.1128/jvi.12.6.1314-1324.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kawai S., Nishizawa M. New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol. 1984 Jun;4(6):1172–1174. doi: 10.1128/mcb.4.6.1172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kewalramani V. N., Panganiban A. T., Emerman M. Spleen necrosis virus, an avian immunosuppressive retrovirus, shares a receptor with the type D simian retroviruses. J Virol. 1992 May;66(5):3026–3031. doi: 10.1128/jvi.66.5.3026-3031.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Koo H. M., Gu J., Varela-Echavarria A., Ron Y., Dougherty J. P. Reticuloendotheliosis type C and primate type D oncoretroviruses are members of the same receptor interference group. J Virol. 1992 Jun;66(6):3448–3454. doi: 10.1128/jvi.66.6.3448-3454.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W. C., Terwilliger E., Dayton A., Rosen C., Haseltine W., Sodroski J. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science. 1987 Sep 11;237(4820):1351–1355. doi: 10.1126/science.3629244. [DOI] [PubMed] [Google Scholar]
  27. Maldonado R. L., Bose H. R., Jr Group-specific antigen shared by the members of the reticuloendotheliosis virus complex. J Virol. 1976 Mar;17(3):983–990. doi: 10.1128/jvi.17.3.983-990.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Martinez I., Dornburg R. Improved retroviral packaging lines derived from spleen necrosis virus. Virology. 1995 Apr 1;208(1):234–241. doi: 10.1006/viro.1995.1147. [DOI] [PubMed] [Google Scholar]
  29. Martinez I., Dornburg R. Mapping of receptor binding domains in the envelope protein of spleen necrosis virus. J Virol. 1995 Jul;69(7):4339–4346. doi: 10.1128/jvi.69.7.4339-4346.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. McKeating J. A., Willey R. L. Structure and function of the HIV envelope. AIDS. 1989;3 (Suppl 1):S35–S41. doi: 10.1097/00002030-198901001-00005. [DOI] [PubMed] [Google Scholar]
  31. Mikawa T., Fischman D. A., Dougherty J. P., Brown A. M. In vivo analysis of a new lacZ retrovirus vector suitable for cell lineage marking in avian and other species. Exp Cell Res. 1991 Aug;195(2):516–523. doi: 10.1016/0014-4827(91)90404-i. [DOI] [PubMed] [Google Scholar]
  32. Morgan R. A., Nussbaum O., Muenchau D. D., Shu L., Couture L., Anderson W. F. Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins. J Virol. 1993 Aug;67(8):4712–4721. doi: 10.1128/jvi.67.8.4712-4721.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Purchase H. G., Witter R. L. The reticuloendotheliosis viruses. Curr Top Microbiol Immunol. 1975;71:103–124. doi: 10.1007/978-3-642-66193-8_3. [DOI] [PubMed] [Google Scholar]
  34. Schulz T. F., Jameson B. A., Lopalco L., Siccardi A. G., Weiss R. A., Moore J. P. Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins? AIDS Res Hum Retroviruses. 1992 Sep;8(9):1571–1580. doi: 10.1089/aid.1992.8.1571. [DOI] [PubMed] [Google Scholar]
  35. Sheay W., Nelson S., Martinez I., Chu T. H., Bhatia S., Dornburg R. Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eukaryotic vectors. Biotechniques. 1993 Nov;15(5):856–862. [PubMed] [Google Scholar]
  36. Smith M. In vitro mutagenesis. Annu Rev Genet. 1985;19:423–462. doi: 10.1146/annurev.ge.19.120185.002231. [DOI] [PubMed] [Google Scholar]
  37. Tsai W. P., Oroszlan S. Site-directed cytotoxic antibody against the C-terminal segment of the surface glycoprotein gp90 of avian reticuloendotheliosis virus. Virology. 1988 Oct;166(2):608–611. doi: 10.1016/0042-6822(88)90535-1. [DOI] [PubMed] [Google Scholar]
  38. Willey R. L., Klimkait T., Frucht D. M., Bonifacino J. S., Martin M. A. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing. Virology. 1991 Sep;184(1):319–329. doi: 10.1016/0042-6822(91)90848-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES